These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Emergence of cardio-oncology. Nebigil CG; Désaubry L Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937 [TBL] [Abstract][Full Text] [Related]
12. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey. Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology. Raschi E; De Ponti F Intern Emerg Med; 2012 Apr; 7(2):113-31. PubMed ID: 22161318 [TBL] [Abstract][Full Text] [Related]
14. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease. Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849 [TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165 [TBL] [Abstract][Full Text] [Related]
16. Cardio-oncology, Immuno-oncology, Onco-cardiology and Onco-immunology. Kounis NG; Koniari I; Hahalis G Int J Cardiol; 2016 Nov; 223():254-257. PubMed ID: 27541667 [No Abstract] [Full Text] [Related]
17. The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters". Abe J; Martin JF; Yeh ET Circ Res; 2016 Sep; 119(8):896-9. PubMed ID: 27688305 [TBL] [Abstract][Full Text] [Related]
18. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967 [TBL] [Abstract][Full Text] [Related]
19. Rationale and proposal for cardio-oncology services in Italy. Galderisi M; Santoro C; Bossone E; Mancusi C J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):207-215. PubMed ID: 32858628 [TBL] [Abstract][Full Text] [Related]
20. Bringing new players into the field: onco-pharmacovigilance in the era of cardio-oncology. Albini A; Donatelli F; Noonan D; D'Elios MM; Prisco D Intern Emerg Med; 2012 Apr; 7(2):99-101. PubMed ID: 22271393 [No Abstract] [Full Text] [Related] [Next] [New Search]